Newly developed approach shows promise in silencing HIV infection
The
HIV virus gets integrated into the infected person's genetic coding and
establishes a constant dormant infection, creating a big treatment challenge.
Because of this, current ART medications fail to cure the virus and when
someone stops the drug, the virus almost always begins to multiply and wreak
havoc. Drug resistance is also a public health issue with the ART medications.
Being able to induce a sustained HIV remission free of ART is an important goal
for HIV treatment."We are the first to show that human BRD4 protein and
its associated machinery can be harnessed to suppress dormant HIV," said
senior author Haitao Hu, UTMB assistant professor in the department of
microbiology and immunology. "Our findings are exciting because they not
only improve our understanding of the biology of HIV epigenetic regulation,
they also present a promising approach for the development of probes and/or
therapeutic agents for HIV silencing, hopefully leading to cure of the virus
eventually."
Comments
Post a Comment